Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
QDEL’s biggest news in Q3, or lack thereof, was its decision not to sell the Point-of-Care (POC) segment. While the company...
— Chris McIntyre
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on QuidelOrtho Corporation
As I argued in the Q1 letter outlining our thesis, QDEL is essentially three different businesses operating under one corporate entity, and a division could be sold to deleverage the co
QDEL is now the fund's largest position, and we have accumulated a full position. To cut to...
As I argued in the Q1 letter outlining our thesis, QDEL is essentially three different businesses operating under one corporate entity, and a division could be sold ...
More institutional theses from McIntyre Partnerships
We had a gain in FTRE, which has continued to rally in Q4. FTRE benefitted from...
We also had smaller losses in STHO, STRZ, and SEG. There was only...
SHC saw positive Q1 results, with the key Sterigenics segment continuing its return to HSD organic growth following the COVID destocking in 2023 and 2024.